Differential immune transcriptomic profiles between vaccinated and resolved HCV reinfected subjects.
Differential immune transcriptomic profiles between vaccinated and resolved HCV reinfected subjects.
复制标题
DOI:
10.1371/journal.ppat.1010968
复制
发表时间:
2022-11
期刊:
影响因子:
6.7
通讯作者:
中科院分区:
文献类型:
--
作者:
Successive episodes of hepatitis C virus (HCV) infection represent a unique natural rechallenge experiment to define correlates of long-term protective immunity and inform vaccine development. We applied a systems immunology approach to characterize longitudinal changes in the peripheral blood transcriptomic signatures in eight subjects who spontaneously resolved two successive HCV infections. Furthermore, we compared these signatures with those induced by an HCV T cell-based vaccine regimen. We identified a plasma cell transcriptomic signature during early acute HCV reinfection. This signature was absent in primary infection and following HCV vaccine boost. Spontaneous resolution of HCV reinfection was associated with rapid expansion of glycoprotein E2-specifc memory B cells in three subjects and transient increase in E2-specific neutralizing antibodies in six subjects. Concurrently, there was an increase in the breadth and magnitude of HCV-specific T cells in 7 out of 8 subjects. These results suggest a cooperative role for both antibodies and T cells in clearance of HCV reinfection and support the development of next generation HCV vaccines targeting these two arms of the immune system. In this study we examined the memory immune response against hepatitis C virus (HCV) upon re-exposure and reinfection followed by spontaneous clearance. This represents a model to define the key immune signatures that should be elicited by a vaccine for long-term protective immunity. We observed that antibodies as well as white blood cells (lymphocyte) responses were induced in the majority of the subjects studied suggesting their cooperative role in protection against HCV. Such a coordinated response was lacking in an experimental HCV vaccine regimen. Altogether, these data suggest that new vaccines against HCV should combine these two arms of the immune system.
登录
查看更多内容
影响因子:
5.8
作者:
Gu, Zuguang;Eils, Roland;Schlesner, Matthias
通讯作者:
Schlesner, Matthias
DOI:
10.1093/bioinformatics/btu638
发表时间:
2015-01-15
期刊:
Bioinformatics (Oxford, England)
影响因子:
--
作者:
Anders S;Pyl PT;Huber W
通讯作者:
Huber W
影响因子:
12.3
作者:
Gentleman RC;Carey VJ;Bates DM;Bolstad B;Dettling M;Dudoit S;Ellis B;Gautier L;Ge Y;Gentry J;Hornik K;Hothorn T;Huber W;Iacus S;Irizarry R;Leisch F;Li C;Maechler M;Rossini AJ;Sawitzki G;Smith C;Smyth G;Tierney L;Yang JY;Zhang J
通讯作者:
Zhang J
影响因子:
29.4
作者:
Osburn WO;Fisher BE;Dowd KA;Urban G;Liu L;Ray SC;Thomas DL;Cox AL
通讯作者:
Cox AL
影响因子:
30.3
作者:
Kinchen VJ;Zahid MN;Flyak AI;Soliman MG;Learn GH;Wang S;Davidson E;Doranz BJ;Ray SC;Cox AL;Crowe JE Jr;Bjorkman PJ;Shaw GM;Bailey JR
通讯作者:
Bailey JR